MTN-016 – EMBRACE
Evaluation of Maternal and Baby Outcome Registry After Chemoprophylactic Exposure – A study that seeks to learn whether HIV prevention products containing ARVs can affect a woman’s pregnancy outcome or her baby’s general growth and development. The study involves the creation of a database of health information collected from women who unintentionally became pregnant while participating in an MTN trial, or who participated in an MTN pregnancy or breastfeeding safety study. Health information about their babies is also included.
MTN-016 Study Protocol